Drug-Herb Interaction between Metformin and Momordica charantia in Diabetic Mice

Asri Dwi Endah Dewi Pramesthi, Mirhansyah Ardana, Niken Indriyanti

Abstract


Background: Bitter gourd has various metabolites, such as momordicosides, polypeptide-P, v-insulin, charantin, and vicine that have antidiabetic effect. It has synergistically effect while combined with oral diabetic drugs, such as metformin as glucose lowering agent. The aim of this study is to investigate the interaction of bitter gourd fruit juice and metformin as glucose lowering agent in mice.

Materials and Methods: Alloxan-induced diabetic mice were treated with bitter gourd fruit juice, metformin, and the combination of those two for 21 days. Glucose level was checked on first and last day of treatment.

Results: Furthermore, blood glucose levels measurement showed no significant difference between groups compared with negative control, which was p>0.05. The stomach of groups that treated with metformin and bitter gourd fruit juice histopathologically showed no significant differences.

Conclusion: The use of bitter gourd once daily together with metformin is a better choice, while twice daily might induce hypoglycemia and mice death. There is no interaction between them on lowering blood glucose.

Keywords: metformin, Momordica charantia, diabetes mellitus


Full Text:

PDF

References


Tan SP, Kha TC, Parks SE, Roach PD. Bitter melon (Momordica charantia L.) bioactive composition and health benefits: a review. Food Rev Int. 2016; 32(2): 181-202, CrossRef.

Lo HY, Li CC, Ho TY, Hsiang CY. Identification of the bioactive and consensus peptide motif from Momordica charantia insulin receptor-binding protein. Food Chem . 2016; 204: 298-305, CrossRef.

Foretz M, Guigas B, Bertrand L, Pollak M, Viollet B. Metformin: from mechanisms of action to therapies. Cell Metab. 2014; 20(6): 953-66, CrossRef.

Baxter K. Book Review: Stockley's Drug Interactions, 7th Edition. Ann. Pharmacother. 2006; 40(6): 1219.

Upadhyay J, Polyzos SA, Perakakis N, Thakkar B, Paschou SA, Katsiki N, et al. Pharmacotherapy of type 2 diabetes: An update. Metabolism. 2018; 78: 13-42, CrossRef.

Subramaniam S, Rosdi MHB, Kuppusamy UR. Customized cooking methods enhance antioxidant, antiglycemic, and insulin-like properties of Momordica charantia and Moringa oleifera. J Food Qual. 2017; 2017: 9561325, CrossRef.

Śmieszek A, Basińska K, Chrząstek K, Marycz K. In vitro and in vivo effects of metformin on osteopontin expression in mice adipose-derived multipotent stromal cells and adipose tissue. 2015; 2015: 814896, CrossRef.

Adak T, Samadi A, Ünal AZ, Sabuncuoğlu S. A reappraisal on metformin. Regul Toxicol Pharmacol. 2018; 92: 324-32, CrossRef.

Maniar K, Moideen A, Mittal A, Patil A, Chakrabarti A, Banerjee D. A story of metformin-butyrate synergism to control various pathological conditions as a consequence of gut microbiome modification: Genesis of a wonder drug ? Pharmacol Res. 2017; 117: 103-28, CrossRef.

Mohamed GA, Ibrahim SRM, Salah R, Dine E. Natural anti-obesity agents. Bull Fac Pharmacy. 2014; 52(2): 269-84, CrossRef.

Selvakumar G, Shathirapathiy G, Jainraj R, Yuvaraj Paul P. Immediate effect of bitter gourd, ash gourd, Knol-khol juices on blood sugar levels of patients with type 2 diabetes mellitus: a pilot study. J Tradit Complement Med. 2017; 7(4): 526-31, CrossRef.

Krawinkel MB, Ludwig C, Swai ME, Yang RY, Chun KP, Habicht SD. Bitter gourd reduces elevated fasting plasma glucose levels in an intervention study among prediabetics in Tanzania. J Ethnopharmacol. 2018; 216: 1-7, CrossRef.

Zhang F, Lin L, Xie J. A mini-review of chemical and biological properties of polysaccharides from Momordica charantia. Int J Biol Macromol. 2016; 92(235): 246-53, CrossRef.

Ahmad N, Hasan N, Ahmad Z, Zishan M, Zohrameena S. Momordica charantia: for traditional uses and pharmacological actions. J Drug Deliv Ther. 2016; 6(2): 40-4, CrossRef.

Golub R, Tan J, Watanabe T, Brendolan A. Origin and immunological functions of spleen stromal cells. Trends Immunol. 2018; 39(6): 503-14, CrossRef.

Out M, Kooy A, Lehert P, Schalkwijk CA, Stehouwer CDA. Long-term treatment with metformin in type 2 diabetes and methylmalonic acid: Post hoc analysis of a randomized controlled 4.3 year trial. J Diabetes Complications. 2018; 32(2): 171-8, CrossRef.

National Toxicology Program [Internet]. Bethesda: US Department of Health and Human Services. Stomach, Glandular Stomach, Epithelium - Hyperplasia [updated: 2014 Nov 18; cited 2018 Dec 1]. Available from: https://ntp.niehs.nih.gov/.




DOI: https://doi.org/10.21705/mcbs.v3i2.47

Copyright (c)

Indexed by:

                     

                    

                    


Cell and BioPharmaceutical Institute